Abstract:Protein Arginine Methyltransferases (PRMTs) are a family of enzymes regulating protein arginine methylation, which is a post-translational modification crucial for various cellular processes. Recent studies have highlighted the mechanistic role of PRMTs in cancer pathogenesis, immunotherapy, and drug resistance. PRMTs are involved in diverse oncogenic processes, including cell proliferation, apoptosis, and metastasis. They exert their effects by methylation of histones, transcription factors, and other regulatory proteins, resulting in altered gene expression patterns. PRMT-mediated histone methylation can lead to aberrant chromatin remodeling and epigenetic changes that drive oncogenesis. Additionally, PRMTs can directly interact with key signaling pathways involved in cancer progression, such as the PI3K/Akt and MAPK pathways, thereby modulating cell survival and proliferation. In the context of cancer immunotherapy, PRMTs have emerged as critical regulators of immune responses. They modulate immune checkpoint molecules, including programmed cell death protein 1 (PD-1), through arginine methylation. Drug resistance is a significant challenge in cancer treatment, and PRMTs have been implicated in this phenomenon. PRMTs can contribute to drug resistance through multiple mechanisms, including the epigenetic regulation of drug efflux pumps, altered DNA damage repair, and modulation of cell survival pathways. In conclusion, PRMTs play critical roles in cancer pathogenesis, immunotherapy, and drug resistance. In this overview, we have endeavored to illuminate the mechanistic intricacies of PRMT-mediated processes. Shedding light on these aspects will offer valuable insights into the fundamental biology of cancer and establish PRMTs as promising therapeutic targets.

The Where and the How of PRMT5

The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

The Structure and Functions of PRMT5 in Human Diseases

Protein arginine methylation of non-histone proteins and its role in diseases.

PRMT5 in gene regulation and hematologic malignancies

Versatility of PRMT5-induced methylation in growth control and development

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

Independent transcriptomic and proteomic regulation by type I and II protein arginine methyltransferases

PRMT5 function and targeting in cancer

Proteomics Profiling of Arginine Methylation Defines PRMT5 Substrate Specificity

Medicinal chemistry insights into PRMT5 inhibitors

The regulation, functions and clinical relevance of arginine methylation

Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity

Chemical probes and methods for the study of protein arginine methylation

Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1

The role of protein arginine methylation 5 in DNA damage repair and cancer therapy

Overview of PRMT1 modulators: Inhibitors and degraders

A systematic survey of PRMT interactomes reveals the key roles of arginine methylation in the global control of RNA splicing and translation

Plant PRMTs broaden the scope of arginine methylation

Crystal structure of the human PRMT5:MEP50 complex

Protein Arginine Methyltransferases (PRMTs): Orchestrators of Cancer Pathogenesis, Immunotherapy Dynamics, and Drug Resistance